GNC HOLDINGS, INC.

Q: Jun 30 2020

Q: Mar 31 2020

FY: Dec 31 2019

FY: Mar 16 2020

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

FY: Dec 31 2018

Q: Sep 30 2018

Q: Jun 30 2018

Q: Mar 31 2018

FY: Dec 31 2017

Q: Sep 30 2017

Q: Jun 30 2017

Q: Mar 31 2017

FY: Feb 16 2017

FY: Dec 31 2016

Q: Sep 30 2016

Q: Jun 30 2016

Q: Mar 31 2016

1.01,1.02,2.01,5.02,9.01

1.01,7.01,8.01,9.01

Regulation FD Disclosure

Entry into a Material Definitive Agreement

1.01,9.01

3.01

1.01,1.03,2.04,5.02,7.01,9.01

1.01,2.03,7.01,9.01

5.07

1.01,2.03,7.01,9.01

2.02,9.01

3.01,7.01,9.01

7.01,9.01

2.02,9.01

5.02

2.02,9.01

2.02,9.01

7.01,9.01

5.02,5.07

2.02,9.01

Certification of termination of registration of a class of securities (Section 12(b))

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notification of removal from listing and/or registration on a national securities exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Free Writing Prospectus

Free Writing Prospectus

Automatic Shelf Registration

Prospectus filed under Rule 424(b)(1)

Amended Initial Registration Statement

Free Writing Prospectus

Notice of Effectiveness

Amended Initial Registration Statement

Free Writing Prospectus

Registration (IPO) statement under Securities Act of 1933

Free Writing Prospectus

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Martindale Kenneth

Harbin Pharmaceutical Group Co., Ltd.

BlackRock Inc.

Tang PC

Harbin Pharmaceutical Group Co., Ltd.

Chow Hsing

HINES MICHAEL F

LANE AMY B

MORAN ROBERT F

FELDMAN ALAN D

MALLOTT PHILIP E

Meyer Michele S.

Wong Yong Kai

Tolivar Tricia K.

none

Seletz Carl

Ostrom Ryan Lee

Canning Susan M.

Tolivar Tricia K.

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

Specialized Disclosure Report

Specialized Disclosure Report

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

No description available